The First Affiliated Hospital of Guangzhou Medical University: Carcinoma, Non-Small-Cell Lung trials

The registry lists 20 Carcinoma, Non-Small-Cell Lung studies with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 10Phase 3 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Low-Frequency rTMS for In-Hospital Sleep Disturbance in Advanced NSCLCNot yet recruitingNCT07796438Phase 2
• Intelligent Pulmonary Rehabilitation After Lung Cancer SurgeryNot yet recruitingNCT07631520Not applicable
• Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLCNot yet recruitingNCT07377916Not applicable
• NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLCNot yet recruitingNCT07318636Phase 1
• Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver MutationsNot yet recruitingNCT06955325Phase 3
• A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLCRecruitingNCT06775275Phase 2
• A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC PatientsRecruitingNCT06118229
• Effect of Exercise Therapy on Psychological State and Clinical Prognosis of Advanced Non-small Cell Lung CancerNot yet recruitingNCT05959265Not applicable
• Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET OverexpressionRecruitingNCT05777278Phase 1/2
• Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLCNot yet recruitingNCT04455594Phase 2
• Real-Time Non-Invasive Localization for Multiple Lung NodulesCompletedNCT07257549Not applicable
• Tubeless VATS for Lung Cancer SurgeryCompletedNCT07057531Not applicable
• A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in ChinaCompletedNCT04830826
• A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung CancerStatus unknownNCT04181372Phase 2
• A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver GenesStatus unknownNCT03710629
• Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung CancerStatus unknownNCT01054482Phase 2
• Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT01051362Phase 2
• Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung CancerStatus unknownNCT00997724Phase 2
• Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung CancerStatus unknownNCT00923637Phase 2
• Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung CancerStatus unknownNCT00862004Phase 2